Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0194 Transporter Info | ||||
Gene Name | SLC25A32 | ||||
Transporter Name | Mitochondrial folate transporter/carrier | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC25A32 Modification Sites with Functional and Structural Information | |||||
Sequence |
MTGQGQSASG SSAWSTVFRH VRYENLIAGV SGGVLSNLAL HPLDLVKIRF AVSDGLELRP
KYNGILHCLT TIWKLDGLRG LYQGVTPNIW GAGLSWGLYF FFYNAIKSYK TEGRAERLEA TEYLVSAAEA GAMTLCITNP LWVTKTRLML QYDAVVNSPH RQYKGMFDTL VKIYKYEGVR GLYKGFVPGL FGTSHGALQF MAYELLKLKY NQHINRLPEA QLSTVEYISV AALSKIFAVA ATYPYQVVRA RLQDQHMFYS GVIDVITKTW RKEGVGGFYK GIAPNLIRVT PACCITFVVY ENVSHFLLDL REKRK |
||||
PTM type |
X-Acetylation
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
Acetylation |
|||||
---|---|---|---|---|---|
Lysine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A32 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
209 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A32 Lysine 209 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine |
7 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A32 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
7 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Serine 7 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A32 | [2] , [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
9 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Serine 9 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A32 | [2] , [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
11 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Serine 11 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A32 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
12 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Serine 12 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLC25A32 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
15 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Serine 15 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 6 |
Have the potential to influence SLC25A32 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
31 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Serine 31 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 7 |
Have the potential to influence SLC25A32 | [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
158 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Serine 158 has the potential to affect its expression or activity. | ||||
Threonine |
6 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A32 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
2 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Threonine 2 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A32 | [2] , [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
16 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Threonine 16 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A32 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
134 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Threonine 134 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A32 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
138 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Threonine 138 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLC25A32 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
144 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Threonine 144 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 6 |
Have the potential to influence SLC25A32 | [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
146 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Threonine 146 has the potential to affect its expression or activity. | ||||
Tyrosine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A32 | [7] , [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
163 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A32 Tyrosine 163 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Leucine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A32 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Leucine |
Modified Location |
148 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A32 Leucine 148 has the potential to affect its expression or activity. | ||||
Lysine |
4 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A32 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
175 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A32 Lysine 175 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A32 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
209 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A32 Lysine 209 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A32 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
272 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A32 Lysine 272 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A32 | [7] , [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
280 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A32 Lysine 280 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.